Synopsis
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INTRAVENOUS - 10MG/10ML (1M...DOSAGE - SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML)
USFDA APPLICATION NUMBER - 203629
DOSAGE - SOLUTION;INTRAVENOUS - 3MG/3ML (1MG/...DOSAGE - SOLUTION;INTRAVENOUS - 3MG/3ML (1MG/ML)
USFDA APPLICATION NUMBER - 203629
DOSAGE - SOLUTION;INTRAVENOUS - 5MG/10ML (0.5...DOSAGE - SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML)
USFDA APPLICATION NUMBER - 203629
DOSAGE - SOLUTION;INTRAVENOUS - 10MG/10ML (1M...DOSAGE - SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML)
USFDA APPLICATION NUMBER - 204078
DOSAGE - SOLUTION;INTRAVENOUS - 5MG/10ML (0.5...DOSAGE - SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML)
USFDA APPLICATION NUMBER - 204078
DOSAGE - SOLUTION;INTRAVENOUS - 5MG/5ML (1MG/...DOSAGE - SOLUTION;INTRAVENOUS - 5MG/5ML (1MG/ML)
USFDA APPLICATION NUMBER - 204078
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
52
PharmaCompass offers a list of Neostigmine Methyl Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Neostigmine Methyl Sulfate manufacturer or Neostigmine Methyl Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Neostigmine Methyl Sulfate manufacturer or Neostigmine Methyl Sulfate supplier.
PharmaCompass also assists you with knowing the Neostigmine Methyl Sulfate API Price utilized in the formulation of products. Neostigmine Methyl Sulfate API Price is not always fixed or binding as the Neostigmine Methyl Sulfate Price is obtained through a variety of data sources. The Neostigmine Methyl Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Proserin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Proserin, including repackagers and relabelers. The FDA regulates Proserin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Proserin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Proserin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Proserin supplier is an individual or a company that provides Proserin active pharmaceutical ingredient (API) or Proserin finished formulations upon request. The Proserin suppliers may include Proserin API manufacturers, exporters, distributors and traders.
click here to find a list of Proserin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Proserin DMF (Drug Master File) is a document detailing the whole manufacturing process of Proserin active pharmaceutical ingredient (API) in detail. Different forms of Proserin DMFs exist exist since differing nations have different regulations, such as Proserin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Proserin DMF submitted to regulatory agencies in the US is known as a USDMF. Proserin USDMF includes data on Proserin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Proserin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Proserin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Proserin Drug Master File in Japan (Proserin JDMF) empowers Proserin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Proserin JDMF during the approval evaluation for pharmaceutical products. At the time of Proserin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Proserin suppliers with JDMF on PharmaCompass.
A Proserin CEP of the European Pharmacopoeia monograph is often referred to as a Proserin Certificate of Suitability (COS). The purpose of a Proserin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Proserin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Proserin to their clients by showing that a Proserin CEP has been issued for it. The manufacturer submits a Proserin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Proserin CEP holder for the record. Additionally, the data presented in the Proserin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Proserin DMF.
A Proserin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Proserin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Proserin suppliers with CEP (COS) on PharmaCompass.
A Proserin written confirmation (Proserin WC) is an official document issued by a regulatory agency to a Proserin manufacturer, verifying that the manufacturing facility of a Proserin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Proserin APIs or Proserin finished pharmaceutical products to another nation, regulatory agencies frequently require a Proserin WC (written confirmation) as part of the regulatory process.
click here to find a list of Proserin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Proserin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Proserin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Proserin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Proserin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Proserin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Proserin suppliers with NDC on PharmaCompass.
Proserin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Proserin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Proserin GMP manufacturer or Proserin GMP API supplier for your needs.
A Proserin CoA (Certificate of Analysis) is a formal document that attests to Proserin's compliance with Proserin specifications and serves as a tool for batch-level quality control.
Proserin CoA mostly includes findings from lab analyses of a specific batch. For each Proserin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Proserin may be tested according to a variety of international standards, such as European Pharmacopoeia (Proserin EP), Proserin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Proserin USP).
